Cargando…
Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9
Curcumin, a principal component of turmeric (Curcuma longa), has potential therapeutic activities against breast cancer through multiple signaling pathways. Increasing evidence indicates that curcumin reverses chemo-resistance and sensitizes cancer cells to chemotherapy and targeted therapy in breas...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269686/ https://www.ncbi.nlm.nih.gov/pubmed/23299550 http://dx.doi.org/10.3390/molecules18010701 |
_version_ | 1783376525462077440 |
---|---|
author | Jiang, Min Huang, Ou Zhang, Xi Xie, Zuoquan Shen, Aijun Liu, Hongchun Geng, Meiyu Shen, Kunwei |
author_facet | Jiang, Min Huang, Ou Zhang, Xi Xie, Zuoquan Shen, Aijun Liu, Hongchun Geng, Meiyu Shen, Kunwei |
author_sort | Jiang, Min |
collection | PubMed |
description | Curcumin, a principal component of turmeric (Curcuma longa), has potential therapeutic activities against breast cancer through multiple signaling pathways. Increasing evidence indicates that curcumin reverses chemo-resistance and sensitizes cancer cells to chemotherapy and targeted therapy in breast cancer. To date, few studies have explored its potential antiproliferation effects and resistance reversal in antiestrogen-resistant breast cancer. In this study, we therefore investigated the efficacy of curcumin alone and in combination with tamoxifen in the established antiestrogen-resistant breast cancer cell lines MCF-7/LCC2 and MCF-7/LCC9. We discovered that curcumin treatment displayed anti-proliferative and pro-apoptotic activities and induced cell cycle arrest at G2/M phase. Of note, the combination of curcumin and tamoxifen resulted in a synergistic survival inhibition in MCF-7/LCC2 and MCF-7/LCC9 cells. Moreover, we found that curcumin targeted multiple signals involved in growth maintenance and resistance acquisition in endocrine resistant cells. In our cell models, curcumin could suppress expression of pro-growth and anti-apoptosis molecules, induce inactivation of NF-κB, Src and Akt/mTOR pathways and downregulate the key epigenetic modifier EZH2. The above findings suggested that curcumin alone and combinations of curcumin with endocrine therapy may be of therapeutic benefit for endocrine-resistant breast cancer. |
format | Online Article Text |
id | pubmed-6269686 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62696862018-12-14 Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9 Jiang, Min Huang, Ou Zhang, Xi Xie, Zuoquan Shen, Aijun Liu, Hongchun Geng, Meiyu Shen, Kunwei Molecules Article Curcumin, a principal component of turmeric (Curcuma longa), has potential therapeutic activities against breast cancer through multiple signaling pathways. Increasing evidence indicates that curcumin reverses chemo-resistance and sensitizes cancer cells to chemotherapy and targeted therapy in breast cancer. To date, few studies have explored its potential antiproliferation effects and resistance reversal in antiestrogen-resistant breast cancer. In this study, we therefore investigated the efficacy of curcumin alone and in combination with tamoxifen in the established antiestrogen-resistant breast cancer cell lines MCF-7/LCC2 and MCF-7/LCC9. We discovered that curcumin treatment displayed anti-proliferative and pro-apoptotic activities and induced cell cycle arrest at G2/M phase. Of note, the combination of curcumin and tamoxifen resulted in a synergistic survival inhibition in MCF-7/LCC2 and MCF-7/LCC9 cells. Moreover, we found that curcumin targeted multiple signals involved in growth maintenance and resistance acquisition in endocrine resistant cells. In our cell models, curcumin could suppress expression of pro-growth and anti-apoptosis molecules, induce inactivation of NF-κB, Src and Akt/mTOR pathways and downregulate the key epigenetic modifier EZH2. The above findings suggested that curcumin alone and combinations of curcumin with endocrine therapy may be of therapeutic benefit for endocrine-resistant breast cancer. MDPI 2013-01-08 /pmc/articles/PMC6269686/ /pubmed/23299550 http://dx.doi.org/10.3390/molecules18010701 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Article Jiang, Min Huang, Ou Zhang, Xi Xie, Zuoquan Shen, Aijun Liu, Hongchun Geng, Meiyu Shen, Kunwei Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9 |
title | Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9 |
title_full | Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9 |
title_fullStr | Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9 |
title_full_unstemmed | Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9 |
title_short | Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9 |
title_sort | curcumin induces cell death and restores tamoxifen sensitivity in the antiestrogen-resistant breast cancer cell lines mcf-7/lcc2 and mcf-7/lcc9 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269686/ https://www.ncbi.nlm.nih.gov/pubmed/23299550 http://dx.doi.org/10.3390/molecules18010701 |
work_keys_str_mv | AT jiangmin curcumininducescelldeathandrestorestamoxifensensitivityintheantiestrogenresistantbreastcancercelllinesmcf7lcc2andmcf7lcc9 AT huangou curcumininducescelldeathandrestorestamoxifensensitivityintheantiestrogenresistantbreastcancercelllinesmcf7lcc2andmcf7lcc9 AT zhangxi curcumininducescelldeathandrestorestamoxifensensitivityintheantiestrogenresistantbreastcancercelllinesmcf7lcc2andmcf7lcc9 AT xiezuoquan curcumininducescelldeathandrestorestamoxifensensitivityintheantiestrogenresistantbreastcancercelllinesmcf7lcc2andmcf7lcc9 AT shenaijun curcumininducescelldeathandrestorestamoxifensensitivityintheantiestrogenresistantbreastcancercelllinesmcf7lcc2andmcf7lcc9 AT liuhongchun curcumininducescelldeathandrestorestamoxifensensitivityintheantiestrogenresistantbreastcancercelllinesmcf7lcc2andmcf7lcc9 AT gengmeiyu curcumininducescelldeathandrestorestamoxifensensitivityintheantiestrogenresistantbreastcancercelllinesmcf7lcc2andmcf7lcc9 AT shenkunwei curcumininducescelldeathandrestorestamoxifensensitivityintheantiestrogenresistantbreastcancercelllinesmcf7lcc2andmcf7lcc9 |